Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > AGM was horrible

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon May 13, 2023 10:53am

256 Views

Post# 35446874

AGM was horrible

I relistened the AGM call once again. So bad, so unenthusiastic at a time the stock price needs a pep talk. My gut tells me to sell this time around since they are clearly bad at what they do. Sorry I will sell my block because I personnally think they will deep six the company in dept and numerous bad decisions. It's their story and it will perpetuate in the prsent form.

<< Previous

Bullboard Posts

Next >>

FLYHT and WestJet partner on weather forecasting